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revealed that the major amount of CRISP1 can be removed from the 
cells by exposure to high ionic strength whereas a minor fraction of the 
protein remains strongly bound to spermatozoa after this treatment and 
can only be removed by agents that release integral proteins.6 Moreover, 
whereas the amount of the tightly-attached CRISP1 population was 
similar in spermatozoa recovered from successive regions of the 
epididymis, the ionically-bound protein increased from caput to cauda, 
suggesting that CRISP1 associates strongly with sperm cells as soon as 
they enter the epididymis and then loosely during epididymal transit.6 
Considering that each epididymal segment has its own pattern of gene 
expression7,8 and that different secretion pathways have been described 
for this organ (i.e., merocrine and apocrine), it is possible that the two 
population of CRISP1 are secreted by different pathways in different 
epididymal regions.
To further characterize the interaction of CRISP1 with spermatozoa, 
we examined whether the exposure of caput or cauda epididymal 
spermatozoa to CRISP1 was sufficient to load the protein on the cells. 
The lack of positive results under all the conditions tested suggested the 
need of another epididymal fluid component to achieve CRISP1-sperm 
interaction. Considering the high concentrations of Zn2+ described in 
the rat epididymis9 and the existence of Zn2+-binding sites in snake 
CRISP proteins,10 we next investigated the possible role of Zn2+ in the 
association of CRISP1 with spermatozoa. Western blot results showed 
an increase in CRISP1 only in extracts from caput spermatozoa that had 
INTRODUCTION
Mammalian fertilization is a complex process that involves different 
steps of interaction between the male and female gametes. Additional 
complexity comes from the fact that the spermatozoa that leave the 
testis are not ready to fertilize the oocyte and need to undergo a 
maturation process as they transit through the epididymis to acquire 
fully fertilizing competence. A  mechanistic understanding of this 
process will certainly improve the chances of developing new methods 
for both treatment of infertility and fertility regulation. As a way to 
contribute to this goal, our laboratory is dedicated to investigating the 
role of epididymal proteins in the acquisition of the sperm fertilizing 
ability during maturation, and the potential use of these proteins for 
contraceptive development. This review describes our contribution to 
the body of knowledge in the field by studying the role of Cysteine-
RIch Secretory Proteins (CRISP) in the different stages of the complex 
mammalian fertilization process.
CRISP PROTEINS AND EPIDIDYMAL SPERM MATURATION
CRISP1, a glycoprotein of 32 kDa first identified in the rat epididymis,1–3 
is expressed by the epithelia in an androgen-dependent manner and 
secreted to the lumen where it associates with the surface of maturing 
spermatozoa.4,5 To study the mechanisms involved in CRISP1 
binding to the cells, mature spermatozoa recovered from the cauda 
epididymidis were subjected to different extraction procedures. Results 
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been incubated with either cauda epididymal fluid or purified CRISP1 in 
the presence of Zn2+.11 Further experiments supported a direct interaction 
between the cation and the protein, and their involvement in high 
molecular weight complexes detected in vitro and in vivo.11 Considering 
that both the amount of CRISP1 loosely associated with spermatozoa6 
and the Zn2+ luminal concentrations12 increase during maturation, our 
results suggested that Zn2+ might be required for the weak association 
of CRISP1 with sperm cells. This was later confirmed by the finding 
that the in vitro-bound protein could be removed from caput cells by 
the same ionic treatment that releases the loosely attached population 
from cauda cells. These observations open the possibility that this novel 
Zn2+-mediated mechanism could be also involved in the binding of other 
proteins to spermatozoa during epididymal maturation.
The association of the tightly-bound population of CRISP1 with 
spermatozoa is less understood. Interestingly, evidence shows the presence 
of small membrane vesicles within the epididymal fluid, known as 
“epididymosomes” and proposed to be involved in the transfer of proteins, 
lipids, and microRNAs to luminal spermatozoa.13 In terms of cholesterol and 
sphingomyelin content, these vesicles are similar to lipid rafts, also called 
detergent-resistant membranes, which are involved in signaling pathways 
and protein and lipid trafficking.13 Interestingly, proteomic analyses revealed 
the presence of CRISP1 in rafts from mouse spermatozoa14 as well as in 
human epididymosomes,15 suggesting the participation of these vesicles in 
the strong association of CRISP1 with spermatozoa during maturation. At 
present, efforts are being made in our laboratory to transfer CRISP1 from 
the epididymosomes onto immature spermatozoa to gain insights into the 
mechanism involved in CRISP1 association with sperm cells and also as an 
approach to increase sperm fertilizing ability in vitro.
In summary, our results suggest the existence of two populations 
of CRISP1, secreted by different segments of the epididymis, that 
bind to spermatozoa through different mechanisms and which, as 
described in the next sections, behave differently during capacitation 
and fertilization.
CRISP PROTEINS AND SPERM CAPACITATION
Different experimental approaches have led us to conclude that 
the ionically-bound CRISP1 protein is released from spermatozoa 
during capacitation, suggesting that this population could be acting 
as a decapacitating factor.5,6 This finding is in agreement with the 
participation of Zn2+ in the weak binding of CRISP1 to spermatozoa,11 
as it is known that loss of this cation from spermatozoa is one of the 
initial steps in the capacitation process.16 In accordance with our results, 
Roberts and colleagues17 postulated that a population of CRISP1 interacts 
in a reversible way with the sperm plasma membrane to modulate 
capacitation, as judged by the fact that exposure of spermatozoa to 
the purified protein inhibited capacitation-associated events, such 
as protein tyrosine phosphorylation and the progesterone-induced 
acrosome reaction. The loose association of CRISP1 with spermatozoa 
and its possible decapacitating role are consistent with what it can be 
expected for an epididymal protein secreted by a merocrine pathway.18
After capacitation, a minor population of CRISP1 remains attached 
to spermatozoa17,19 and behaves as the tightly-bound CRISP1.6 This 
protein migrates from the dorsal region of the acrosome to the 
equatorial segment concomitantly with the occurrence of the acrosome 
reaction,20 and plays a role in the fertilization process as described in 
detail below.
CRISP PROTEINS AND FERTILIZATION
The bulk of evidence supports the participation of CRISP1 in the 
fertilization process.21 Initially, results from our group revealed that 
CRISP1 participates in an event following the binding of spermatozoa 
to the oocyte plasma membrane, leading to gamete fusion.22 These 
studies also showed that CRISP1 binds to complementary sites on 
the oocyte surface, with CRISP1 and its partner localized in the 
fusogenic regions of the spermatozoon and oocyte, respectively.20,22,23 
Subsequent results revealed that the oocyte-binding ability of CRISP1 
resides within the N-terminal domain of the molecule and, more 
specifically, in a region of only 12 amino acids24 that corresponds 
to a defining feature of all CRISP family members. In addition to 
this role in gamete fusion, experiments from our group showed that 
CRISP1 also participates in the initial step of sperm binding to the 
zona pellucida  (ZP) through its interaction with complementary 
sites localized in this glycoprotein matrix.25 To further examine the 
role of CRISP1 in fertilization, we generated a mouse line deficient 
in CRISP1, which represented the first knockout animal for a 
CRISP protein.26 Analysis of CRISP1 in spermatozoa by Western 
blots revealed the existence of two populations of the protein in the 
mouse gamete (i.e., one that is released during capacitation and one 
that remains in the capacitated sperm cells) and the lack of both 
populations in the knockout cells (Figure 1a). In vitro fertilization 
studies confirmed the previously-proposed roles of the protein 
in fertilization, as CRISP1-deficient spermatozoa exhibit a clear 
disadvantage in their ability to interact with both the ZP and the egg 
plasma membrane compared with controls.26 Interestingly, despite 
these fertilizing ability deficiencies, normal fertilization rates were 
observed when CRISP1 knockout spermatozoa were co-incubated with 
cumulus-intact oocytes,26 suggesting that CRISP1 could be expressed 
by the oocyte or cumulus cells and compensate for the lack of CRISP1 
in the null sperm cells. Consistent with this possibility, CRISP1 exhibits 
57% homology with allurin,27 a CRISP protein synthesized by the 
amphibian oviduct28 and which binds to the vitelline coat surrounding 
the egg.29 Studies are being conducted in our laboratory to confirm 
whether CRISP1 is expressed by the cumulus-oocyte complexes and 
plays an additional role during fertilization.
Figure 1: (a) Fate of CRISP1 during mouse sperm capacitation. Total protein 
extracts from equal amounts of fresh (F) and capacitated (C) epididymal 
spermatozoa collected from either Crisp1+/− or Crisp1−/− animals were analyzed 
by SDS-PAGE and Western blots using an anti-CRISP1 antibody (α-CRISP1). 
β-tubulin was used as control of loading (α-tub). (b) Evaluation of tyrosine 
phosphorylation in CRISP1-null spermatozoa. Fresh (F) and capacitated (C) 
epididymal spermatozoa from Crisp1+/− or Crisp1−/− animals were subjected 
to flow cytometric analysis with an anti-phospho tyrosine antibody. The 
figure shows representative histograms for each genotype. The gray 
histograms correspond to sperm cells incubated with normal IgG as primary 
antibody (negative control). The mean fluorescence intensity (MFI) ± s.e.m. 
of three experiments is shown as an inset, *P < 0.05.
b
a
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In addition to these features, CRISP1 knockout spermatozoa do not 
exhibit the characteristic increase in protein tyrosine phosphorylation 
associated with sperm capacitation.26 Recent analysis of these 
spermatozoa by flow cytometry showed that this decrease does not 
occur as a consequence of the lack of tyrosine phosphorylation in a 
group of cells but rather to a decrease in phosphorylation in most of 
the cells (Figure 1b). These observations, together with those reported 
for the rat,17 support the idea that CRISP1 plays a regulatory role in 
the intracellular transduction pathways leading to protein tyrosine 
phosphorylation during capacitation.
In spite of the sperm fertilizing ability deficiencies, CRISP1-null 
animals exhibited normal fertility rates, suggesting the existence of 
compensatory mechanisms involving other homolog proteins. In 
this regard, it is important to note that besides CRISP1, three other 
CRISP proteins have been reported in mammals  (CRISP2-4).30 
Whereas CRISP2 and CRISP4 are exclusively found in the testis 
and epididymis, respectively, CRISP3 exhibits a tissue distribution 
beyond the reproductive tract.30 Considering results from our group 
showing that testicular CRISP2 also participates in gamete fusion by 
binding to the same oocyte-complementary sites as CRISP1,24,31 it is 
likely that CRISP2 cooperates with CRISP1 to ensure the success of 
fertilization. Further studies are undergoing in our laboratory to test 
whether CRISP2 deficiency produces an effect on mouse fertility and/ 
or fertilization. Another protein that could compensate for the lack of 
CRISP1 in the knockout model is epididymal CRISP4. Results have 
shown that mice carrying a deletion in the crisp4 gene are fertile, but 
exhibit spermatozoa with a reduced ability to bind to the ZP and to 
undergo the acrosome reaction in response to progesterone.32,33 On 
the basis of this, CRISP4 could be partially compensating the impaired 
sperm-ZP binding ability of CRISP1 KO mice, whereas CRISP1 could 
be doing so in the CRISP4 knockout mice. The generation of mice 
deficient in more than one CRISP will provide key information on 
both the existence of cooperation between CRISP homolog members 
and the relevance of these proteins for animal fertility.
CRISP PROTEINS IN HUMANS
Rodent CRISP1 exhibits 50% homology with a CRISP protein expressed 
in the human epididymis known as hCRISP1.34,35 Besides its common 
tissue origin, hCRISP1 is also a glycoprotein of 30 kDa that associates 
with the sperm surface during epididymal maturation.34,35 These 
features, together with results showing the existence of a tightly-bound 
population of hCRISP1 in spermatozoa,36 led us to explore a possible 
role of hCRISP1 in human fertilization. For ethical reasons, these 
studies were carried out with approaches that involve the use of human 
and rodent gametes. Our results showed that an anti-hCRISP1 antibody 
significantly inhibits the ability of human spermatozoa to penetrate 
ZP-free hamster oocytes, and that recombinant hCRISP1 binds to 
the surface of ZP-free human oocytes, supporting the participation of 
hCRISP1 in gamete fusion.36 Further experiments were performed in 
order to investigate whether hCRISP1, as its rodent counterpart, could 
also mediate the binding of spermatozoa to the ZP. In this case, we used 
the hemizona (HZ) assay in which matching halves of human ZP from 
nonliving oocytes are exposed to capacitated human spermatozoa. 
The results revealed that the presence of anti-hCRISP1 during gamete 
co-incubation produced a significant inhibition in the number of 
sperm cells bound per HZ compared with controls.37 As hCRISP1 is 
capable of binding to human ZP-intact oocytes, human recombinant 
proteins ZP2, ZP3, and ZP4 expressed in insect cells were co-incubated 
with hCRISP1 to examine protein–protein interactions by ELISA. The 
finding that hCRISP1 mostly interacts with ZP3 in a dose-dependent 
manner supports the involvement of the protein in sperm–ZP 
binding through its specific interaction with human ZP3.37 There are 
only three crisp genes in the human genome,30 unlike the rodent’s, in 
which four CRISP proteins have been identified. Moreover, hCRISP1 
exhibits a higher sequence homology with rodent CRISP4 (70%) than 
with rodent CRISP1 (50%), suggesting that hCRISP1 represents the 
human molecule functionally equivalent to both rodent CRISP1 and 
CRISP4.30,37
Interesting data have come from epididymal transcriptome 
studies in men who have undergone vasectomy.38 Results  showed 
that hCRISP1 mRNA is up-regulated in the cauda epididymis of 
vasectomized men.38 Consistent with this, an increase in hCRISP1 
expression has also been observed in the epididymis of azoospermic 
men.39 Furthermore, after vasectomy reversal, fertility is not recovered 
in more than 50% of the cases, and hCRISP1 expression remains high 
as a sequelae in the epididymis.40 In fact, the amount of hCRISP1 
in spermatozoa from vaso-vasostomized men is higher than that 
of healthy donors.40 In addition to these observations, ejaculated 
spermatozoa from vaso-vasostomized men exhibit higher protein 
tyrosine phosphorylation,40 a finding consistent with our data 
showing that mouse sperm cells lacking CRISP1 show lower levels 
of tyrosine phosphorylation.26 Thus, modifications in the level of 
hCRISP1 expression may disrupt the signaling cascade underlying 
capacitation, with potential implications for human fertility, as 
suggested by the poor recovery of fertility of men with vasectomy 
reversal. As the levels of soluble hCRISP1 in seminal plasma also 
vary in cases of obstruction below the epididymis, hCRISP1 has 
been proposed as a diagnostic marker for the distinction of different 
types of azoospermia.41
In addition to hCRISP1, the human epididymis expresses 
CRISP3, a protein which is absent from the rat epididymis and also 
expressed in the mouse by the accessory glands.42,43 On the basis of 
this observation, we next investigated the potential involvement of 
human CRISP3  (hCRISP3) in fertilization. Initial results showed 
that hCRISP3 was present in ejaculated human spermatozoa as two 
isoforms of 29 kDa and 31 kDa (depending on its glycosylation state). 
Whereas the 31  kDa is released during capacitation, the 29  kDa 
form remains attached to sperm after capacitation and the acrosome 
reaction  (Figure  2a). Subsequent indirect immunofluorescence 
experiments localized hCRISP3 in the acrosome and tail of 
capacitated sperm cells42 and in the equatorial segment of calcium 
ionophore-induced acrosome reacted cells  (Figure  2b), suggesting 
the involvement of hCRISP3 in gamete fusion. Evaluation of this 
possibility with the hamster oocyte penetration test revealed that the 
anti-hCRISP3 antibody did not produce a decrease in the percentage 
of penetrated oocytes, contrary to what was observed for the 
anti-hCRISP1 and anti-hCRISP2 antibodies  (Figure  2c). Although 
these observations suggest that hCRISP3 does not participate in 
gamete fusion, the potential involvement of this protein in sperm–ZP 
interaction remains to be explored.
CRISP PROTEINS AND CONTRACEPTION
On the basis of the participation of CRISP proteins in different 
stages of the fertilization process, our laboratory explored their 
potential use for male contraceptive development. As a first 
approach, male and female rats were immunized with CRISP1 
and both the immune response and animal fertility were 
evaluated. Results revealed that immunization with either native 
or recombinant rat CRISP1 produced specific antibodies against 
the protein in over  90% of the animals, as well as a significant 
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and reversible inhibition of fertility in both sexes.44–46 These 
observations support the idea that epididymal proteins are good 
candidates for posttesticular contraception, as they are specifically 
involved in the acquisition of sperm fertilizing ability and not in 
key processes such as spermatogenesis or hormone production. In 
spite of the disadvantage of using testicular proteins, immunization 
experiments were also carried out with recombinant testicular 
CRISP2. The lack of immune response and the normal fertility of 
immunized males and females were consistent with the intracellular 
localization of CRISP2.47 In view of the results obtained with 
rodent CRISP1, we next explored the potential contraceptive use of 
epididymal hCRISP1 in a nonhuman primate model. Immunization 
of male and female monkeys with recombinant hCRISP1 elicited 
a specific and reversible immune response.48 Furthermore, 
results revealed the presence of specific antibodies against the 
protein bound to ejaculated spermatozoa from hCRISP1- but not 
control-immunized animals, confirming the entry of the antibodies 
into the male reproductive tract and their ability to bind to sperm 
cells.48 These results together with the finding that anti-hCRISP1 
antibodies are capable of inhibiting the ability of spermatozoa both 
to fuse with the oocyte36 and to bind to the ZP37 support hCRISP1 
as an epididymal contraceptive target.
PERSPECTIVES
Evidence obtained by using different cellular, molecular and genetic 
approaches supports different roles for CRISP proteins in sperm 
function in rodents as well as in humans. According to our observations 
and those reported by other groups, these molecules accompany sperm 
along their transit through both the male and female reproductive 
tracts. Functional studies of the different CRISP members revealed 
overlapping roles in the fertilization process (Figure 3), supporting 
the existence of a functional redundancy and cooperation between 
these homolog protein members, ensuring the success of fertilization. 
We believe these results will contribute to a better understanding of 
the mechanisms involved in the acquisition of sperm fertilizing ability 
during epididymal maturation, as well as to the development of new 
methods for diagnosis and treatment of human infertility and fertility 
regulation.
Figure 3: CRISP proteins in spermatozoa during their transit along the male 
and female reproductive tracts. Spermatozoa leaving the testis carry CRISP2 
inside the head and tail. During epididymal transit, CRISP1, CRISP3, and 
CRISP4, soluble or associated with epididymosomes, bind loosely or strongly 
to the sperm surface. CRISP3 can also bind to the cells during ejaculation. 
In the female tract, the loosely associated proteins are partially released from 
sperm cells during capacitation whereas the intracellular or tightly-bound 
population remain in the cells and relocalize to the equatorial segment of 
acrosome-reacted spermatozoa. Each sperm CRISP protein participates in 
more than one step of fertilization and cooperates with other CRISP homologs 
in each fertilization step.
Figure 2: (a) Behavior of CRISP3 during human sperm capacitation and the 
acrosome reaction. Total protein extracts of fresh (F), capacitated (C) and 
ionophore-treated (C + I) sperm were analyzed by SDS-PAGE and Western 
blots with an anti-hCRISP3 antibody (α-CRISP3). (b) Localization of CRISP3 
in human spermatozoa. Representative phase contrast (upper panels) and 
fluorescence (lower panels) microphotographs of human capacitated (C) and 
ionophore-treated (C + I) spermatozoa subjected to immunofluorescence 
labeling with α-CRISP3 or normal IgG as primary antibodies. (c) Relevance 
of CRISP3 for human sperm fusion ability. Capacitated spermatozoa were 
incubated for 15 min in medium containing either normal IgG, α-CRISP3-, 
α-CRISP1- or α-CRISP2-antibodies, then co-incubated with ZP-free hamster 
oocytes for 2.5 h and the percentage of penetrated oocytes was determined. 
Results represent the mean ± s.e.m. of at least three independent experiments, 
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